• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用釉基质衍生物在微创/无瓣技术中的应用:系统评价与荟萃分析。

Use of Enamel Matrix Derivative in Minimally Invasive/Flapless Approaches: A Systematic Review with Meta-Analysis.

出版信息

Oral Health Prev Dent. 2022 Jul 13;20:233-242. doi: 10.3290/j.ohpd.b3125655.

DOI:10.3290/j.ohpd.b3125655
PMID:35695693
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11641140/
Abstract

PURPOSE

The aim of the present systematic review with meta-analysis was to investigate the clinical effectiveness of EMD (enamel matrix derivative) using a minimally invasive surgical technique (MIST) or flapless approach for the treatment of severe periodontal probing depths.

MATERIALS AND METHODS

A systematic review of the literature including searches in PubMed/Medline, Cochrane Library, Google Scholar, and Grey Literature databases as well as manual searches was performed on September 1st, 2021. Studies utilising EMD in a non-surgical or minimally invasive approach were included. The eligibility criteria comprised randomised controlled trials (RCTs) comparing minimally-invasive/flapless approaches with/without EMD for the treatment of probing depths >5 mm.

RESULTS

From 1525 initial articles, 7 RCTs were included and 12 case series discussed. Three studies investigated a MIST approach, whereas 3 studies utilised a flapless approach. One study compared EMD with either a MIST or a flapless approach. The RCTs included ranged from 19-49 patients with at least 6 months of follow-up. While 5 of the studies included smokers, patients smoking >20 cigarettes/day were excluded from the study. The meta-analysis revealed that EMD with MIST improved recession coverage (REC) and bone fill (BF) when compared to MIST without EMD. However, no difference in CAL or PD was observed between MIST + EMD vs MIST without EMD. No statistically significant advantage was found for employing the EMD via the flapless approach.

CONCLUSIONS

Implementing EMD in MIST procedures displayed statistically significant improvement in REC and BF when compared to MIST alone. These findings suggest that MIST in combination with EMD led to improved clinical outcomes while EMD employed in nonsurgical flapless therapy yielded no clinical benefits when compared to nonsurgical therapy alone without EMD. More research is needed to substantiate these findings.

摘要

目的

本系统评价和荟萃分析的目的是研究使用微创外科技术(MIST)或无瓣技术治疗重度牙周探诊深度的 EMD(釉基质衍生物)的临床疗效。

材料和方法

于 2021 年 9 月 1 日对文献进行了系统评价,包括在 PubMed/Medline、Cochrane 图书馆、Google Scholar 和灰色文献数据库中进行检索以及手动检索。纳入了使用 EMD 进行非手术或微创治疗的研究。纳入标准包括比较微创/无瓣方法与有无 EMD 治疗探诊深度>5mm 的随机对照试验(RCT)。

结果

从 1525 篇初始文章中,纳入了 7 项 RCT 和 12 项病例系列讨论。3 项研究调查了 MIST 方法,3 项研究使用了无瓣方法。一项研究比较了 EMD 与 MIST 或无瓣方法。纳入的 RCT 范围从 19 到 49 例患者,随访时间至少 6 个月。虽然 5 项研究包括吸烟者,但每天吸烟>20 支的患者被排除在研究之外。荟萃分析显示,与不使用 EMD 的 MIST 相比,使用 EMD 的 MIST 可改善退缩覆盖(REC)和骨填充(BF)。然而,在 MIST+EMD 与 MIST 之间,CAL 或 PD 没有观察到差异。通过无瓣技术使用 EMD 没有发现统计学上的优势。

结论

与单独使用 MIST 相比,在 MIST 中使用 EMD 可显著改善 REC 和 BF。这些发现表明,MIST 联合 EMD 可改善临床结局,而与单独使用非手术治疗相比,在无瓣治疗中使用 EMD 并未带来临床获益。需要更多的研究来证实这些发现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/054d/11641140/2e04f5fdda02/ohpd-20-233-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/054d/11641140/24938f9975de/ohpd-20-233-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/054d/11641140/119c71735028/ohpd-20-233-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/054d/11641140/f5ee6542f0c5/ohpd-20-233-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/054d/11641140/ce364e5e7b05/ohpd-20-233-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/054d/11641140/1fe0e173f132/ohpd-20-233-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/054d/11641140/2e04f5fdda02/ohpd-20-233-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/054d/11641140/24938f9975de/ohpd-20-233-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/054d/11641140/119c71735028/ohpd-20-233-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/054d/11641140/f5ee6542f0c5/ohpd-20-233-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/054d/11641140/ce364e5e7b05/ohpd-20-233-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/054d/11641140/1fe0e173f132/ohpd-20-233-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/054d/11641140/2e04f5fdda02/ohpd-20-233-g006.jpg

相似文献

1
Use of Enamel Matrix Derivative in Minimally Invasive/Flapless Approaches: A Systematic Review with Meta-Analysis.使用釉基质衍生物在微创/无瓣技术中的应用:系统评价与荟萃分析。
Oral Health Prev Dent. 2022 Jul 13;20:233-242. doi: 10.3290/j.ohpd.b3125655.
2
The role of surgical flap design (minimally invasive flap vs. extended flap with papilla preservation) on the healing of intrabony defects treated with an enamel matrix derivative: a 12-month two-center randomized controlled clinical trial.手术皮瓣设计(微创皮瓣与保留乳头的扩展皮瓣)对应用釉基质衍生物治疗的骨内缺损愈合的影响:一项为期 12 个月的双中心随机对照临床试验。
Clin Oral Investig. 2022 Feb;26(2):1811-1821. doi: 10.1007/s00784-021-04155-5. Epub 2021 Sep 7.
3
Enamel matrix derivative (Emdogain) for periodontal tissue regeneration in intrabony defects. A Cochrane systematic review.釉基质衍生物(Emdogain)用于骨内缺损牙周组织再生的Cochrane系统评价。
Eur J Oral Implantol. 2009 Winter;2(4):247-66.
4
A novel flapless approach versus minimally invasive surgery in periodontal regeneration with enamel matrix derivative proteins: a 24-month randomized controlled clinical trial.采用釉基质衍生蛋白进行牙周再生时,一种新型无瓣方法与微创手术的对比:一项为期24个月的随机对照临床试验。
Clin Oral Investig. 2017 Jan;21(1):327-337. doi: 10.1007/s00784-016-1795-2. Epub 2016 Apr 5.
5
The use of enamel matrix derivative alone versus in combination with bone grafts to treat patients with periodontal intrabony defects: a meta-analysis.单独使用釉基质衍生物与联合使用骨移植物治疗牙周内骨缺损患者的疗效:一项荟萃分析。
J Am Dent Assoc. 2012 Sep;143(9):e46-56. doi: 10.14219/jada.archive.2012.0327.
6
Enamel matrix derivative (Emdogain(R)) for periodontal tissue regeneration in intrabony defects.用于骨内缺损牙周组织再生的釉基质衍生物(Emdogain®)
Cochrane Database Syst Rev. 2009 Oct 7;2009(4):CD003875. doi: 10.1002/14651858.CD003875.pub3.
7
Clinical evaluation of demineralized freeze-dried bone allograft and enamel matrix derivative versus enamel matrix derivative alone for the treatment of periodontal osseous defects in humans.脱矿冻干骨同种异体移植物与釉基质衍生物联合应用与单独使用釉基质衍生物治疗人类牙周骨缺损的临床评估。
J Periodontol. 2004 Oct;75(10):1309-18. doi: 10.1902/jop.2004.75.10.1309.
8
Enamel matrix derivative (Emdogain) for periodontal tissue regeneration in intrabony defects.釉基质衍生物(Emdogain)用于骨内缺损的牙周组织再生。
Cochrane Database Syst Rev. 2005 Oct 19(4):CD003875. doi: 10.1002/14651858.CD003875.pub2.
9
Treatment of intrabony defects using guided tissue regeneration or enamel matrix derivative: a 3-year prospective randomized clinical study.使用引导组织再生术或釉基质衍生物治疗骨内缺损:一项为期3年的前瞻性随机临床研究。
J Periodontol. 2008 Dec;79(12):2281-9. doi: 10.1902/jop.2008.080135.
10
The flapless approach with and without enamel matrix derivatives for the treatment of intrabony defects: A randomized controlled clinical trial.无瓣切口联合和不联合釉基质衍生物治疗骨内缺损的随机对照临床试验。
J Clin Periodontol. 2024 Sep;51(9):1112-1121. doi: 10.1111/jcpe.14028. Epub 2024 Jun 10.

引用本文的文献

1
Research progress of enamel matrix derivative on periodontal tissue regeneration: a narrative review.釉基质衍生物在牙周组织再生方面的研究进展:一篇叙述性综述。
Front Dent Med. 2025 Jun 30;6:1611402. doi: 10.3389/fdmed.2025.1611402. eCollection 2025.
2
Effects of enamel matrix derivative in nonsurgical periodontal therapy on pro-inflammatory profiles, microbial environment and clinical outcome: a randomized clinical trial.在非手术性牙周治疗中应用釉基质衍生物对促炎因子谱、微生物环境和临床效果的影响:一项随机临床试验。
Clin Oral Investig. 2023 Nov;27(11):6493-6502. doi: 10.1007/s00784-023-05254-1. Epub 2023 Oct 16.

本文引用的文献

1
Oral biofilms revisited: A novel host tissue of bacteriological origin.口腔生物膜再探:一种源于宿主组织的新型细菌生境。
Periodontol 2000. 2021 Jun;86(1):8-13. doi: 10.1111/prd.12374. Epub 2021 Mar 10.
2
The dental plaque biofilm matrix.牙菌斑生物膜基质。
Periodontol 2000. 2021 Jun;86(1):32-56. doi: 10.1111/prd.12361. Epub 2021 Mar 10.
3
Flapless application of enamel matrix derivative in periodontal retreatment: A multicentre randomized feasibility trial.无瓣应用 enamel matrix derivative 在牙周翻修中的应用:一项多中心随机可行性试验。
J Clin Periodontol. 2021 May;48(5):659-667. doi: 10.1111/jcpe.13438. Epub 2021 Mar 9.
4
Application of enamel matrix derivative in conjunction with non-surgical therapy for treatment of moderate to severe periodontitis: A 12-month, randomized prospective, multicenter study.釉基质衍生物联合非手术治疗中重度牙周炎的应用:一项为期 12 个月的随机前瞻性多中心研究。
J Periodontol. 2021 May;92(5):619-628. doi: 10.1002/JPER.19-0579. Epub 2020 Oct 21.
5
The prevention of periodontal disease-An overview.牙周病的预防概述。
Periodontol 2000. 2020 Oct;84(1):9-13. doi: 10.1111/prd.12330.
6
Contemporary practices for mechanical oral hygiene to prevent periodontal disease.当代机械口腔卫生保健实践预防牙周病。
Periodontol 2000. 2020 Oct;84(1):35-44. doi: 10.1111/prd.12332.
7
What periodontal recall interval is supported by evidence?有哪些证据支持的牙周病复查间隔?
Periodontol 2000. 2020 Oct;84(1):124-133. doi: 10.1111/prd.12340.
8
Local application of enamel matrix derivative prevents acute systemic inflammation after periodontal regenerative surgery: A randomized controlled clinical trial.局部应用釉基质衍生物可预防牙周再生手术后的急性全身炎症:一项随机对照临床试验。
J Clin Periodontol. 2020 Jun;47(6):747-755. doi: 10.1111/jcpe.13270. Epub 2020 Mar 12.
9
RoB 2: a revised tool for assessing risk of bias in randomised trials.《随机对照试验偏倚风险评估工具2:修订版》
BMJ. 2019 Aug 28;366:l4898. doi: 10.1136/bmj.l4898.
10
Histologic evidence of periodontal regeneration in furcation defects: a systematic review.牙周再生的组织学证据:系统评价。
Clin Oral Investig. 2019 Jul;23(7):2861-2906. doi: 10.1007/s00784-019-02964-3. Epub 2019 Jun 4.